Analyst Price Target is $2.20
▲ +146.89% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Ginkgo Bioworks in the last 3 months. The average price target is $2.20, with a high forecast of $3.00 and a low forecast of $1.10. The average price target represents a 146.89% upside from the last price of $0.89.
Current Consensus is
Hold
The current consensus among 5 contributing investment analysts is to hold stock in Ginkgo Bioworks. This Hold consensus rating has held steady for over two years.
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Read More